Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis
Biogen Inc. (Nasdaq: BIIB) and Bio-Thera Solutions, Ltd. (688177.SH) today announced that they entered into a […]
Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers
Early results show that a new combination drug therapy is safe and effective against advanced […]
Sanofi Acquires Tidal Therapeutics
Sanofi today acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel […]
New Roche Data at 2021 AAN Highlight Neuroscience Portfolio
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data for its approved and […]
Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials
Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for […]
Empatica First to Receive European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables
Digital biomarker and medical device company Empatica is awarded CE-certification for its Aura system to detect and […]
Teva Pharmaceuticals Receives European Approval for Spiromax Inhalers
Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair Spiromax […]
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
Antiparasitic Drug Could Prevent Coronavirus Lung Damage
A common antiparasitic drug could block lung damage in people with coronavirus, according to new […]
NHSBT: First Blood Plasma for Medicines Donations Begin
NHS Blood and Transplant (NHSBT) will from today take donations at 14 donor centres around […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more